These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 9251065

  • 1. The emerging role of clozapine in the treatment of movement disorders.
    Factor SA, Friedman JH.
    Mov Disord; 1997 Jul; 12(4):483-96. PubMed ID: 9251065
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clozapine use in Parkinson's disease: a retrospective analysis of a large multicentered clinical experience.
    Trosch RM, Friedman JH, Lannon MC, Pahwa R, Smith D, Seeberger LC, O'Brien CF, LeWitt PA, Koller WC.
    Mov Disord; 1998 May; 13(3):377-82. PubMed ID: 9613725
    [Abstract] [Full Text] [Related]

  • 7. High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias.
    Storch A, Trenkwalder C, Oehlwein C, Winkelmann J, Polzer U, Hundemer HP, Schwarz J.
    Parkinsonism Relat Disord; 2005 Sep; 11(6):393-8. PubMed ID: 15993640
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The use of clozapine in neurologic disorders.
    Safferman AZ, Kane JM, Aronowitz JS, Gordon MF, Pollack S, Lieberman JA.
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():98-101. PubMed ID: 7961585
    [Abstract] [Full Text] [Related]

  • 10. Current use of clozapine in Parkinson disease and related disorders.
    Thomas AA, Friedman JH.
    Clin Neuropharmacol; 2010 Sep; 33(1):14-6. PubMed ID: 20023573
    [Abstract] [Full Text] [Related]

  • 11. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM, Leucht S, Carpenter D, Docherty JP, Expert Consensus Panel for Optimizing Pharmacologic Treatment of Psychotic Disorders.
    J Clin Psychiatry; 2003 Sep; 64 Suppl 12():5-19. PubMed ID: 14640142
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Rater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson's disease psychosis.
    Merims D, Balas M, Peretz C, Shabtai H, Giladi N.
    Clin Neuropharmacol; 2006 Sep; 29(6):331-7. PubMed ID: 17095896
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Psychosis in nursing home patients with Parkinson's disease.
    Kang GA, Bronstein JM.
    J Am Med Dir Assoc; 2004 Sep; 5(3):167-73. PubMed ID: 15115577
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Atypical antipsychotics in the elderly].
    van Melick EJ, Werkgroep Klinische Gerontofarmacologie.
    Tijdschr Gerontol Geriatr; 2004 Dec; 35(6):240-5. PubMed ID: 15704604
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.